Delisting riskPopularity #4,718
cbdMD (YCBD)
Develops cannabinoid wellness, pet CBD, mushroom supplements, and THC beverages.
$0.4943
After hours−0.00 (−0.76%)
At close$0.4981(+13.20%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Sep 2023 | Q1 FY24Dec 2023 | Q2 FY24Mar 2024 | Q3 FY24Jun 2024 | Q4 FY24Sep 2024 | Q1 FY25Dec 2024 | Q2 FY25Mar 2025 | Q3 FY25Jun 2025 | Q4 FY25Sep 2025 | Q1 FY26Dec 2025 | Q2 FY26Mar 2026 | Q3 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 |
| Cost of revenue | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| Gross profit | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| 5 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 4 | 4 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 4 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating income | −2 | −1 | −1 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | −1 | −1 |
| −14 | 0 | −2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 14 | 0 | 1 | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | −16 | −1 | −3 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | −1 | −1 |
| Net income from continuing operations | −16 | −1 | −3 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | −1 | −1 |
| Net income | −16 | −1 | −3 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | −1 | −1 |
| EPS, basic | −$5.70 | −$0.67 | −$1.35 | −$0.15 | −$0.27 | −$0.22 | −$0.29 | −$0.21 | −$0.08 | −$0.04 | −$0.08 | −$0.11 |
| EPS, diluted | −$5.70 | −$0.67 | −$1.35 | −$0.15 | −$0.27 | −$0.22 | −$0.19 | −$0.21 | −$0.08 | −$0.04 | −$0.08 | −$0.11 |
| Weighted average shares, basic | 3 | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 9 | 9 | 10 | 11 |
| Weighted average shares, diluted | 3 | 3 | 3 | 4 | 4 | 5 | 8 | 6 | 9 | 9 | 10 | 11 |
| EBITDA | −15 | 0 | −2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −16 | −1 | −3 | 0 | 0 | 0 | 0 | −1 | −1 | 0 | −1 | −1 |